Ethicon, Inc.

ethicon.com

At Ethicon, we believe amazing things happen when you bring people together with a common purpose. We are committed to help advance surgical care so that more patients live longer, more fulfilling lives. We are driven to develop meaningful solutions, enabling our customers to provide the treatment and positive outcomes patients deserve. For more than 80 years, we have provided healthcare professionals with value-driven, best-to-market solutions. The videos within our playlists display the use of Ethicon medical devices in a variety of specialties.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

ETHICON ANNOUNCES AGREEMENT TO ACQUIRE NEUWAVE MEDICAL, INC.

Ethicon, Inc. | March 07, 2016

news image

Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems. Their products are currently used by physicians in over half of the top cancer centers in the United States....

Read More

NEW DATA RELEASED ON EVARREST® FIBRIN SEALANT PATCH AS A HEMOSTATIC ADJUNCT IN AORTIC RECONSTRUCTION SURGERY

Ethicon, Inc. | March 05, 2016

news image

Ethicon* today announced new data from a global cardiovascular (CV) Phase III clinical trial of the EVARREST® Fibrin Sealant Patch. Seventy five percent of patients treated during aortic reconstruction surgery with EVARREST® achieved hemostasis on the first attempt within three minutes and maintained hemostasis throughout the duration of the surgery, as compared to 45 percent for those treated with Baxter’s TachoSil®. Results from this investigational study will be presented at...

Read More

BETTER TECHNICAL SERVICES NEEDED TO IMPROVE EHR USER SATISFACTION

EHRIntelligence | January 16, 2020

news image

Eighty-four percent of EHR users are dissatisfied with the technical service and basic software account support from current EHR and HIT vendors, according to a 2020 Black Book Research survey. Since the HITECH Act was signed into law in 2009, EHRs have not only been more prevalent, but they have continued to change and evolve. However, technical service from EHR vendors hasn’t kept up with the constant change, according to high-level hospital tech managers. Healthcare software support is ...

Read More

RIDE HEALTH RAISES MILLIONS TO COORDINATE THE MEDICAL TRANSPORTATION ECOSYSTEM

Managed Healthcare Executive | January 15, 2020

news image

Ride Health, providing smarter transportation for every patient need, announced they raised $6.2 million in a funding round led by Activate Venture Partners. The capital raise is joined by Newark Venture Partners, Anthro Ventures, BioAdvance, Leading Edge Ventures and Startup Health, according to a news release from Cision PR Newswire. Ride Health will use the funds in an initiative of ensuring every patient, everywhere, has access to the care and resources they need to ensure good health. Ride ...

Read More
news image

ETHICON ANNOUNCES AGREEMENT TO ACQUIRE NEUWAVE MEDICAL, INC.

Ethicon, Inc. | March 07, 2016

Ethicon, a medical device company of the Johnson & Johnson family of companies, today announced a definitive agreement to acquire NeuWave Medical, Inc., a privately held medical device company that manufactures and markets minimally invasive soft tissue microwave ablation systems. Their products are currently used by physicians in over half of the top cancer centers in the United States....

Read More
news image

NEW DATA RELEASED ON EVARREST® FIBRIN SEALANT PATCH AS A HEMOSTATIC ADJUNCT IN AORTIC RECONSTRUCTION SURGERY

Ethicon, Inc. | March 05, 2016

Ethicon* today announced new data from a global cardiovascular (CV) Phase III clinical trial of the EVARREST® Fibrin Sealant Patch. Seventy five percent of patients treated during aortic reconstruction surgery with EVARREST® achieved hemostasis on the first attempt within three minutes and maintained hemostasis throughout the duration of the surgery, as compared to 45 percent for those treated with Baxter’s TachoSil®. Results from this investigational study will be presented at...

Read More
news image

BETTER TECHNICAL SERVICES NEEDED TO IMPROVE EHR USER SATISFACTION

EHRIntelligence | January 16, 2020

Eighty-four percent of EHR users are dissatisfied with the technical service and basic software account support from current EHR and HIT vendors, according to a 2020 Black Book Research survey. Since the HITECH Act was signed into law in 2009, EHRs have not only been more prevalent, but they have continued to change and evolve. However, technical service from EHR vendors hasn’t kept up with the constant change, according to high-level hospital tech managers. Healthcare software support is ...

Read More
news image

RIDE HEALTH RAISES MILLIONS TO COORDINATE THE MEDICAL TRANSPORTATION ECOSYSTEM

Managed Healthcare Executive | January 15, 2020

Ride Health, providing smarter transportation for every patient need, announced they raised $6.2 million in a funding round led by Activate Venture Partners. The capital raise is joined by Newark Venture Partners, Anthro Ventures, BioAdvance, Leading Edge Ventures and Startup Health, according to a news release from Cision PR Newswire. Ride Health will use the funds in an initiative of ensuring every patient, everywhere, has access to the care and resources they need to ensure good health. Ride ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us